ArticleActa parasitologica2026
Prevalence and Subtypes of Blastocystis in Symptomatic Children in Egypt and Anti-Blastocystis Efficacy of Artemisia alba-Loaded Silver Nanoparticles In Vitro and in Swiss Albino Mice.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBlastocystis hominis (B. hominis) is a common protozoan pathogen that affects the health of both humans and animals. This study aimed to investigate the prevalence of Blastocystis in children and evaluate the effects of Artemisia alba aqueous extract-loaded silver nanoparticles (AgNPs) on B. hominis infection, both in vitro and in mice.
methodsFresh fecal samples were collected from 235 children and analyzed for the presence of B. hominis using microscopy and culture techniques. Fifty positive samples were further subtyped using subtype-specific primers through PCR. Additionally, the effectiveness of Artemisia alba aqueous extract-loaded AgNPs in treating B. hominis infection was assessed both in vitro and in Swiss albino mice.
resultsOf the 235 children's fecal samples, 75 (32%) tested positive for B. hominis. Genotyping of 50 positive samples revealed that ST3 was the most common genotype, followed by ST1, ST2, and ST4. The results of the second phase showed that treatment with Artemisia alba aqueous extract-loaded AgNPs significantly inhibited the growth of Blastocystis in culture. Additionally, it significantly reduced the number of Blastocystis cysts found in the feces of treated mice. Furthermore, this treatment had minimal adverse effects on the liver, kidney, and intestine, especially when compared to metronidazole.
conclusionBlastocystis is commonly found among children, with subtype ST3 being the most prevalent. The administration of Artemisia alba aqueous extract-loaded AgNPs demonstrated significant anti-Blastocystis activity, both in vitro and in vivo. Furthermore, the treatment was shown to be safe and may represent a promising option for addressing blastocystosis.
Indexed as
Identifiers
41661452What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.